Basics Hutchison China MediTech Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases. IPO Date: March 17, 2016 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $2.83B Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 1.99% Avg Daily Range (30 D): $0.15 | 0.91% Avg Daily Range (90 D): $0.20 | 1.33% Institutional Daily Volume Avg Daily Volume: .17M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 904 Avg Inst. Trade: $1.68M Avg Inst. Trade (30 D): $2.99M Avg Inst. Trade (90 D): $2.4M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.6M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $.53M Avg Closing Volume: 75.62K     News Jun 4, 2025 @ 11:45 PM HUTCHMED and Innovent Jointly Announce NDA Accepta... Source: Hutchmed (China) Limited And Innovent Biologics, Inc. May 13, 2025 @ 7:00 AM International companies to host live webcasts at D... Source: N/A May 13, 2025 @ 12:00 AM International companies to host live webcasts at D... Source: N/A Apr 22, 2025 @ 12:00 AM HUTCHMED Completes Patient Enrollment of a PhaseÂ... Source: Hutchmed Mar 21, 2025 @ 10:00 AM HUTCHMED Announces NMPA Conditional Approval for T... Source: Hutchmed Splits Apr 20, 2009:   1:50